# Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

Source: https://onco.cc/trials/nct06573398/  
OnCo record `nct06573398` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of tislelizumab in pancreatic cancer, run by Ruijin Hospital, not yet recruiting.

## Summary

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC is a phase 2, interventional study registered as NCT06573398 by Ruijin Hospital, with a registry enrolment figure of 20 participants, started 2024-09-01 and due to reach its primary completion in 2025-09-01. Interventions recorded: SBRT with Sequential AG regimen +Tislelizumab+Thymalfasin. Conditions listed: Carcinoma, Pancreatic Ductal. Primary outcome: R0 resection rate. Pancreatic eligibility wording from the registry: "Histologically or cytologically confirmed diagnosis of ductal adenocarcinoma of pancreas;". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06573398
- Phase: 2
- Setting: Efficacy and Safety of Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for Borderline Resectable Pancreatic Cancer
- Sponsor: Ruijin Hospital
- Enrolled: 20

## Sources

- ClinicalTrials.gov NCT06573398: https://clinicaltrials.gov/study/NCT06573398

## Connected records

- cancers: [Borderline resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/borderline-resectable-pdac/), [Resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/resectable-pdac/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [SBRT / SABR (stereotactic radiotherapy)](https://onco.cc/technologies/sbrt/)
- drugs: [Tislelizumab](https://onco.cc/drugs/tislelizumab/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06573398.json